LUNG - Pulmonx Corporation
NEXT EARNINGS:
Mar 4, 2026
(in 7 days)
EPS Est: $-0.39
|
Rev Est: $21.7M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$4.00
DETAILS
HIGH:
$4.00
LOW:
$4.00
MEDIAN:
$4.00
CONSENSUS:
$4.00
UPSIDE:
164.90%
Market Cap:
62.28M
Volume:
200,217
Avg Volume:
585,606
52 Week Range:
1.31-9.32
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.07
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
291
IPO Date:
2020-10-01
EPS (TTM):
-1.44
P/E Ratio:
-4.71
Revenue (TTM):
83.79M
Total Assets:
162.85M
Total Debt:
56.47M
Cash & Equiv:
70.91M
Rev Growth (5Y):
20.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-37.8%
Debt/Equity:
0.66
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-0.34 | $-0.40 | +15.0% | $21.5M | $21.7M | -1.0% |
| 2025-07-30 | $-0.38 | $-0.40 | +5.0% | $23.9M | $23.4M | +2.0% |
| 2025-04-30 | $-0.36 | $-0.37 | +2.7% | $22.5M | $22.0M | +2.3% |
| 2025-02-19 | $-0.33 | $-0.45 | +26.7% | $23.8M | $22.3M | +6.6% |
| 2024-10-30 | $-0.36 | $-0.43 | +16.3% | $20.4M | $22.3M | -8.5% |
| 2024-07-31 | $-0.39 | $-0.41 | +4.9% | $20.8M | $20.1M | +3.2% |
| 2024-05-01 | $-0.36 | $-0.43 | +16.3% | $18.9M | $17.9M | +5.4% |
| 2024-02-21 | $-0.36 | $-0.39 | +7.7% | $19.3M | $18.3M | +5.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 83.79M | 68.67M | 53.66M | 48.42M | 32.73M | 32.59M | 20.00M |
| Net Income | (56.39M) | (60.84M) | (58.92M) | (48.66M) | (32.23M) | (20.70M) | (18.48M) |
| EPS | -1.44 | -1.60 | -1.59 | -1.35 | -0.90 | -0.58 | -0.89 |
| Total Assets | 162.85M | 177.78M | 193.68M | 235.17M | 263.71M | 53.53M | 15.01M |
| Total Debt | 56.47M | 41.42M | 24.40M | 26.46M | 27.22M | 227.15M | 33.60M |
| Cash & Equivalents | 70.91M | 83.55M | 101.74M | 148.48M | 231.79M | 14.77M | 4.12M |
| Operating Cash Flow | (31.54M) | (37.61M) | (45.14M) | (41.43M) | (30.63M) | (20.77M) | (18.39M) |
| Free Cash Flow | (32.98M) | (38.42M) | (46.45M) | (45.10M) | (31.54M) | (21.48M) | (18.71M) |
| FCF per Share | -0.84 | -1.01 | -1.25 | -1.25 | -0.88 | -0.61 | -0.90 |
| Book Value | 85.81M | 118.31M | 154.01M | 193.24M | 226.13M | (187.38M) | (167.33M) |
| Cash & ST Investments | 101.48M | 117.10M | 141.14M | 180.04M | 231.79M | 28.35M | 4.12M |
| ROC Equity | -0.66 | -0.51 | -0.38 | -0.25 | -0.14 | N/A | N/A |